Shield Therapeutics Postpones IPO Due to Unfavourable Market Conditions

Oct 5 Shield Therapeutics Plc (IPO-SHIE.L)

• Shield Therapeutics postpones its initial public offering due to unfavourable market conditions

• Recent increase in volatility currently does not allow co to launch IPO and achieve smooth transition to public markets Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

Help employers find you! Check out all the jobs and post your resume.

Back to news